confirmed that ABCB5 can be used as a molecular marker for MSCs, ABCB5(+) melanoma cells had a higher tumorigenic potential than the ABCB5(-) somatic cell population in subsequent mouse xenograft trials, which re-established clinical tumour heterogeneity. The gene discussed is ABCB5; the disease is neoplasm.